Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 18th March, 2020 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 18th March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
18-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.

 The Company has received disclosure dated 18th March, 2020 under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 17th March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
18-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 18th March, 2020 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 17th March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
18-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.

 The Company has received disclosure dated 14th March, 2020 under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 13th March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
16-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 14th March, 2020 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 13th March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
16-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.

 The Company has received disclosure dated 14th March, 2020 under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 12th March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
16-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015

 The Company has received disclosure dated 14th March, 2020 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 12th March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
16-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Resignation of Director

 Sub.: Resignation of Mr. Nisarg Anilbhai Shah as an Independent Director of the Company with immediate effect. Dear Sir/Madam, With reference to abovementioned subject, we hereby inform you that Mr. Nisarg Anilbhai Shah have resigned as an Independent Director of the Company w.e.f. 28.02.2020. Pursuant to Regulation 30 (7A), we hereby confirm that there is no material reason for his resignation, other than those provided in the attached resignation letter. Kindly take the same on record.
28-02-2020
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sir / Ma'am, We hereby wish to inform you that the Unaudited financial results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2019 were approved at the meeting of Board of Directors held on 13th February, 2020. In continuation to the same, the newspaper clipping duly published in English Newspaper (All Edition) dated 14th February, 2020 and Gujarati Newspaper (Ahmedabad Edition) dated 15th February, 2020 is enclosed herewith. This is for your information and records.
15-02-2020
Bigul

Medico Intercontinental Ltd - 539938 - Results - Unaudited Standalone And Consolidated Financial Results For 31/12/2019

 Dear Sir/Ma'am, Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., February 13, 2020, inter alia, considered and approved: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2019 along with Limited Review report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Unaudited Standalone and Consolidated Financial Results along with limited review report for the quarter and nine months ended on December 31, 2019' and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 03:00 P.M and concluded at 03:45 PM. This is for your information and records.
13-02-2020
Next Page
Close

Let's Open Free Demat Account